Showing results (651-660 of 810) with videos related to
Sort By:
Pageof 81
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|July 16, 2011
Structural and functional comparative mapping between the Brassica A genomes in allotetraploid Brassica napus and diploid Brassica rapaCongcong Jiang, Nirala Ramchiary, Yongbiao Ma, et al.The New Phytologist|July 16, 2016
The loss of vernalization requirement in narrow-leafed lupin is associated with a deletion in the promoter and de-repressed expression of a Flowering Locus T (FT) homologueMatthew N Nelson, Michał Książkiewicz, Sandra Rychel, et al.Heliyon|September 7, 2023
Genetic and molecular analysis of stem rot (Sclerotinia sclerotiorum) resistance in Brassica napus (canola type)Muhammad Azam Khan, Wallace A Cowling, Surinder Singh Banga, et al.Advances in Therapy|December 18, 2021
Interpretation of the Meaningfulness of Symptom Reduction with Vibegron in Patients with Overactive Bladder: Analyses from EMPOWURJeffrey Frankel, David Staskin, Susann Varano, et al.Molecular Microbiology|June 30, 2019
The dormancy-specific regulator, SutA, is intrinsically disordered and modulates transcription initiation in Pseudomonas aeruginosaMegan Bergkessel, Brett M Babin, David VanderVelde, et al.Blood|January 3, 2012
A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signalingPeisong Ma, Aleksandra Cierniewska, Rachel Signarvic, et al.Health Promotion Practice|October 22, 2019
Novel (Multilevel) Focus Group Training for a Transdisciplinary Research ConsortiumJeni Hebert-Beirne, Lisa Kane Low, Kathryn L Burgio, et al.Molecular Phylogenetics and Evolution|June 10, 2004
Mitochondrial evidence for the origin of hamadryas baboonsDerek E Wildman, Thore J Bergman, Abdulwali al-Aghbari, et al.Biological Psychiatry|January 18, 2005
Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeysTimothy K Newman, Yana V Syagailo, Christina S Barr, et al.Seizure|April 12, 2002
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimenD W Chadwick, T A Betts, H G Boddie, et al.Pageof 81